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exchange of protons between the ﬁbrillating peptide and its surroundings may play an important
role in ﬁbrillation. Here, we use isothermal titration calorimetry to measure exchange of protons
between buffer and the peptide hormone glucagon during ﬁbrillation. Glucagon absorbs or releases
protons to an extent which allows it to attain a net charge of zero in the ﬁbrillar state, both at acidic
and basic pH. Similar results are obtained for lysozyme. This suggests that side chain pKa values
change dramatically in the ﬁbrillar state.
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Formation of amyloid ﬁbrils is associated with neurodegenera-
tive diseases such as Alzheimer´s, Parkinson´s, Huntington´s and dia-
betes type II [1]. Although the proteins causing amyloid diseases
show large sequence diversity, they all form the same cross-b
structure i.e., b-strands arranged perpendicular to the long ﬁbril
axis, giving rise to a characteristic ﬁber diffraction pattern [2]. This
highly repetitive molecular architecture makes ﬁbrils a useful
model system for aggregation in general [3]. Fibrillation can
broadly be divided into two steps: a rate-limiting nucleation step
where the ﬁbril nucleus or seed is formed, and an elongation step
where monomers are incorporated into the growing end of the ﬁ-
bril [4,5]. While the nucleation step can be a stochastic process
with variable lag times, it is possible to start the elongation process
by adding pre-made ﬁbril seeds to the solution, making it easily to
control the process [5,6]. This elongation process has been shown
to proceed readily for a number of proteins, also under conditions
where the polypeptide carries a signiﬁcant net charge. Clearly, a
build-up of this charge is irreconcilable with the occurrence of sta-
ble, macroscopic ﬁbrils, and it follows that elongation must be
associated with some mechanism that relieves the accumulationchemical Societies. Published by E
nsoluble Protein Structures
sity of Aarhus, Gustav Wieds
31 78.of charge in the aggregate. Some examples of possible mechanisms
include ion-bridging, co-assimilation of counter ions or neutraliza-
tion by acid-base reactions. As electrostatic forces tend to domi-
nate the stability of any colloidal system [7], the mechanism that
alleviates charge accumulation during elongation is likely to be a
key element for the understanding of the ﬁbrillation process. The
elongation of a ﬁbril can be schematically represented as one
monomer (M) attaching to an already made ﬁbril (F) [8]:
F þM $ F ð1Þ
This reaction may couple to absorption or release of protons from
the protein to the buffer:
M  nHþ þ Buffer $ M þ Buffer  nHþ ð2Þ
The observed enthalpy for ﬁbril elongation (DHobs) may be ex-
pressed as follows [9,10]:
DHobs ¼ DHintrinsic þ DHion  nHþ ð3Þ
whereDHion is the ionization enthalpy of the buffer and DHintrinsic is
the enthalpy change that would have been measured in an
experiment with a buffer that had DHion = 0. DHintrinsic is devoid
of (irrelevant) contributions pertaining to the choice of buffer, and
reﬂects the peptide-ﬁbril interaction (including a possible uptake
or release of protons by the peptide). Thus DHintrinsic provides a bet-
ter measure than DHobs of the thermodynamics of the elongation
process. It follows from Eq. (3) that if the enthalpy of the elongation
process is measured at the same pH but in different buffers (withlsevier B.V. All rights reserved.
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on both the extent of proton exchange (slope) and the enthalpy of
ﬁbrillation (intercept). The best way to measureDHobs is by Isother-
mal Titration Calorimetry (ITC). Kardos, Goto and co-workers have
developed a simple and elegant protocol for measuring ﬁbril elon-
gation enthalpy, where a solution of monomeric protein is titrated
into a suspension of ﬁbril seeds made from the same protein [11].
The fact that it is possible to measure the heat of formation of a well
deﬁned aggregation structure makes ﬁbrils ideal for aggregation
studies. Using the Kardos–Goto approach to measure the elongation
enthalpy in various buffers, it is possible to separate the measured
elongation enthalpy DHobs into a variable contribution from the
buffer’s proton ionization (DHion) as well as a constant buffer-inde-
pendent step related to the intrinsic heat of elongation (DHintrinsic).
Here, we use the peptide hormone glucagon to measure the role
of protonation in ﬁbrillation. Its small size (29 residues), high pro-
pensity to ﬁbrillate under a range of different conditions and com-
plete incorporation of the entire sequence into the structure makes
it a very appropriate model for these studies [12–15]. Our data
indicate a requirement for electric neutrality in the ﬁbrillar
structure.2. Materials and methods
2.1. Isothermal titration calorimetry
All experiments were conducted on a VP-ITC (MicroCal, North-
ampton, MA). Immediately prior to measurements, all solutions
were degassed under vacuum with a ThermoVac accessory from
MicroCal.
2.2. Determination of DHion
We carried out ﬁve injections of 10 ll 0.01 M HCl from the ITC
syringe into the cell (volume 1.42 ml) ﬁlled with 50 mM buffer pH
2.0, 2.5, or pH 9.5. The four buffers used at pH 2.5 were glycine,
proline, histidine and citric acid (pH adjusted with HCl or NaOH
as required), the four at pH 2.0 were serine, theonine, methionine,
leucine and lysine (pH adjusted with HCl) and the four buffers used
at pH 9.5 were glycine, lysine, Bis–tris and boric acid (pH adjusted
with NaOH). For reproducibility, ﬁve injections of 10 ll each, sep-
arated by a 180 s equilibration, were made after an initial injection
of 3 ll. We injected with HCl at pH 2.5 and with NaOH at ph 9.5. In
all cases, the amount of HCl or NaOH added only titrated a small
amount of the base from of the buffer in the cell. A typical titration
proﬁle is shown in Fig. 1A.
2.3. Glucagon experiments
Pharmaceutical grade glucagon (>98%) was generously provided
by Dr. Hans Aage Hjuler, Novo Nordisk A/S. To measure the elonga-
tion enthalpyDHobs, ﬁbrils were initially prepared by incubation in
each in the four buffers at 25 C at a concentration of 0.5 mg/ml
glucagon with continuous shaking for 24 h in a thermostated Vor-
temp 56EVC shaker (Tehtnica, Zˇelezniki, Slovenia). These condi-
tions are known to induce very efﬁcient glucagon ﬁbrillation
[12]. The pre-made ﬁbrils were transferred to the ITC cell, after
which glucagon monomer (0.5 mg/ml) was injected into the cell.
For reproducibility, ﬁve injections of 40 ll each, separated by a
1000 s equilibration, were made after an initial injection of 3 ll.
The enthalpy for the 5 injections was plotted as a function of total
injection volume and DHobs was obtained by linear extrapolation
to zero volume. This extrapolation was necessary because we ob-
serve a small decline in the enthalpy after each injection, probably
because of a decline in the monomer concentration due to ongoingﬁbrillation in the syringe. Data analysis of each of the ITC runs was
done using ITC Data Analysis in MicroCal Origin 7.0.
2.4. Lysozyme experiments
Hen egg white lysozyme ﬁbril seeds were prepared by incuba-
tion of a 3 mg/ml solution of lysozyme at 60 C for 72 h in an
eppendorf shaker [16]. For elongation studies, we used 3 mg/ml
lysozyme ﬁbrils in the cell and injected with 3 mg/ml lysozyme
monomer in the syringe using the same procedure as for glucagon.
The ﬁve buffers (50 mM, pH 2, pH adjusted with HCl) were the free
acids serine, theonine, methionine, leucine and lysine. DHobs and
DHion were measured at 60 C.
2.5. Circular dichroism wavelength scans
All ﬁbril samples were sonicated 30 s prior to recording. CD
spectra were measured using a 0.2 mm quartz cell in a Jasco J-
810 CD-spectrometer at 25 C with scan speed 50 nm/min, band
width 1 nm and response time two seconds. All reported CDvalues
of are in mean residue ellipticities [h] = (100 h)/(c d), where h is the
measured ellipticity in degrees, c is the amino acid residue concen-
tration in mol/l and d is the path length in cm.
2.6. Atomic force microscopy (AFM)
Four microlitre of 0.5 mg/ml glucagon ﬁbrils were dried on
freshly cleaved mica for 10 min at ambient temperature, washed
with 1 ml milli Q water and dried for 20 min. AFM imaging was
performed using a commercial Nanoscope IV MultiModeAFM
(Veeco Instruments, Santa Barbara, CA) under ambient conditions
in the tapping mode at scan frequencies of 1–2 Hz with minimal
loading forces applied and by optimized feedback parameters to
minimize sample distortion by tip compression. Silicon nitride can-
tilevers (LTESP, Veeco Instruments) were used with a resonance
frequency of 150 kHz, a spring constant of 48 N/m, and a tip radius
of <10 nm. The AFM images were obtained by recording 512  512
pixels, and several images were always obtained from separate
locations across the sample to ensure that data presented are rep-
resentative of the actual surface morphology. All AFM images were
globally ﬂattened and visualized using the commercial Scanning
Probe Image Processor software (SPIP, Image Metrology ApS, Ver-
sion 4.2, Lyngby, Denmark).3. Results and discussion
3.1. The number of protons exchanged under ﬁbrillation equals the
charge of the peptide
Fig. 1B shows an example of ITC measurements of glucagon
ﬁbrillation. Elongation of the ﬁbrils in the calorimetric cell is asso-
ciated with an exothermic heat ﬂow that lasts 100–500 s. The
peaks were integrated to get DHobs. In accordance with Eq. (3), a
plot of DHobs measured at both pH 2.5 and 9.5 versus DHion reveals
a linear relationship (Fig. 1C and D), although the slopes and inter-
cepts are clearly different at the two pH values (Table 1). At pH 2.5
the slope of DHobs versus DHion was 5.32 ± 0.08, indicating that ﬁve
protons are released for each glucagon monomer that attaches to
the ﬁbril. Interestingly, this number corresponds to the total
charge of monomeric glucagon at pH 2.5, (N-terminus, His1,
Lys12, Arg17 and Arg18). All our available evidence suggests that
the entire sequence of glucagon is incorporated into the ﬁbril
structure (C. B. Andersen and D.E.O., unpublished observations).
This means that the entire sequence has to be electrically neutral
to avoid excess concentration of charges. At pH 9.5, the slope of
Fig. 1. ITC data used to determine the number of protons released during glucagon ﬁbrillation. (A) ITC titration data used to obtain the protonation enthalpy DHion for various
buffers, here titration of NaOH into glycine at pH 2.5. (B) ITC titration data used to obtain DHobs. Five times 40 ll monomeric glucagon (0.5 g/l) is titrated into glucagon ﬁbril
seeds, here in 50 mM glycine pH 9.5. DHobs is the area under the peaks. (C)DHobs for glucagon at pH 2.5 as a function of DHion. (D)DHobs for glucagon at pH 9.5 as a function of
DHion. In both panels C and D, data are ﬁtted to Eq. (3) and summarized in Table 1. For panels C and D, there are error bars in both dimensions.
Table 1
Thermodynamic parameters of te glucagon and lysozyme ﬁbrillation.
Parameter Glucagon pH 2.5 Glucagon pH 9.5 Lysozyme pH 2
DHintrinsic (kcal/
mol)a
0.36 ± 0.18 8.3 ± 0.05 31 ± 1.5
nHþ
b 5.32 ± 0.08 1 ± 0.01 21 ± 4.2
a Intrinsic enthalpy of ﬁbril elongation obtained by ﬁtting data in Figs. 1 and 2 to
Eq. (3).
b Number of protons exchanged for each molecule elongated into the ﬁbrils (Eq.
(3)).
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change of 1 in monomeric glucagon (Asp9, Asp15, Asp21 and
the C-terminus outweighing Lys12, Arg 17 and Arg18). We titrate
with NaOH at pH 9.5 (rather than HCl as at pH 2.5), and therefore
the slope of +1 corresponds to an uptake of 1 proton. Thus the ﬁbril
can attain electric neutrality by absorbing or releasing protons, and
thereby avoids excess accumulation of charge, consistent with the
fact that a ‘‘super-charged” molecule would be inherently unsta-
ble.Glucagon’s primary sequence does not immediately reveal
how glucagon can release ﬁve protons at pH 2.5. The ﬁve functional
groups with the lowest pKa values are His1, Asp 9, Asp 15, Asp 21
and the C-terminus. We cannot exclude that these ﬁve groups will
donate protons, but if this is the case, then six side chains (Asp 9,Asp 15, Asp 21, Lys 12, Arg 17 and Arg 18) and the two termini
(1/3 of the entire peptide) will be charged, which will impose se-
vere restrictions on packing of the ﬁbrils. An alternative scenario is
that the ﬁve positively charged groups (His1, Lys12, Arg17, Arg 18
and the N-terminal) all release their protons (for the sake of argu-
ment we here exclude the two Tyr residues which could also re-
lease protons and become negatively charged). This will lead to a
completely uncharged peptide and facilitate packing. However,
the high pKa values of Lys and Arg in solution (10.5 and 12,
respectively) means that deprotonation of these residues (as well
as that of the Tyr side chain, with a pKa 11) is highly unfavour-
able. Thus, a release of a proton from Arg at pH 2.5 will contribute
RT ln ½Hþ=Ka
 
(13 kcal/mol) to the free energy of the elongation
process. This unfavourable contribution would have to be compen-
sated by attractive (but not electrostatic) intermolecular interac-
tions in the ﬁbril.
To test if our neutrality theory also works for other proteins we
measured the amount of protons released when hen egg white
lysozyme ﬁbrils elongate at pH 2 and 60 C (Fig. 2). Lysozyme re-
leases around 20 protons (Table 1), which nicely corresponds to
a lysozyme net charge of +20 at pH 2 (1 His, 6 Lys, 12 Arg and
the N-terminal). That the theory also works for lysozyme is good
evidence that it is the charged residues which become neutral
rather than a compensation effect of other amino acids in the mol-
ecule. Particularly for large proteins with many complementary
Fig. 2. The elongation enthalpy for lysozyme ﬁbrillation plotted as a function of the
buffer ionization enthalpy. The buffers used for ﬁbrillation are the indicated free
amino acids. There are error bars in both dimensions. Data summarized in Table 1.
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impose large restrictions on the packing of the ﬁbrillar structure.
Nevertheless, we cannot exclude that the ﬁbril structure contains
a mixture of contributions, so that some side chains are neutralized
by proton release/uptake and others form salt bridges. A ﬁnal res-
olution will require access to atomic-resolution ﬁbril structures.
3.2. Small dissimilarities in the glucagon ﬁbrils made in different
buffers do not affect the observed elongation enthalpy
Eq. (3) implicitly presumes that we are studying the same pro-
cess in different buffers systems. If the structure of the ﬁbrils wereFig. 3. Atomic Force Microscopy of glucagon ﬁbrilssigniﬁcantly different in the four buffers (at the same pH) this
could translate into differences in DHobs unrelated to proton ex-
change. Glucagon is known to form different ﬁbrils under different
conditions, e.g., temperature, concentration and salt [12]. To assess
this, we studied the structure of the ﬁbrils. AFM reveals that the
glucagon ﬁbrils prepared in the different buffers have the same
classical ﬁbrillar appearance (Fig. 3). The CD scans show only insig-
niﬁcant variation in the structure of the ﬁbrils in different buffers
at pH 9.5 (Fig. 4). At pH 2.5, the spectrum of the ﬁbrils formed in
citrate clearly deviate from the other three buffers, but match
those of ﬁbrils formed at higher temperatures [12], indicating that
they belong to another class of ﬁbrils with other secondary struc-
ture and stability. Nevertheless this structural difference does not
affect the excellent linear correlation between DHobs and DHion
(Fig. 1C). Note however that the enthalpy associated with the ex-
change of protons at pH 2.5 (1–4 kcal/mol) is very high compared
to DHintrinsic at pH 2.5 (0.36 ± 0.18 kcal/mol), suggesting that
changes in structure at this pH will not lead to large changes in
DHintrinsic.
We note in general that intrinsic enthalpy changes for ﬁbrilla-
tion found here and elsewhere [11] are small. Lysozyme, for exam-
ple, shows an exothermic enthalpy change of about 100 kcal/mol
when folding into the native state [17]. This is three times more
than the enthalpy change for incorporating unfolded lysozyme into
a ﬁbril (Table 1). Also, ﬁbrillation of glucagon at pH 2.5 is essen-
tially athermal. These low enthalpy changes will have to be in-
cluded in future discussions of the driving forces that underlie
the ﬁbrillation process.
In summary, we have shown that the ﬁbrillation of glucagon
and lysozyme ﬁbrils coincides with the release of a number of pro-
tons sufﬁcient to cause overall electric neutrality. This suggests
that co-assimilation of inorganic counterions is not involved in
charge regulation in the growing ﬁbril, thus leaving salt-bridging
and/or neutralization as possible mechanisms. If the amino acidformed in 50 mM of different buffers at pH 2.5.
Fig. 4. Circular dichroism spectra of glucagon ﬁbrils formed at (A) pH 2.5 and (B) pH 9.5. The CD spectrum of ﬁbrils in histidine pH 2.5 do not extend below 220 nm, due to
large background absorbance by histidine. However, the spectrum down to 220 nm coincides closely with those in glycine and proline buffer.
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severe restrictions on the structural arrangements, as it requires
oppositely charged side chains to be spatially close. To our knowl-
edge, there are no atomic level structures available which would be
able to address these issues for ﬁbrils formed under conditions
where deprotonation is extremely unfavourable. Hopefully this
will be resolved by e.g., future solid-state NMR structures, which
can determine side chains’ protonation states.
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